CX3CL1 and nonpapillary renal cell carcinoma: We found that CX3CL1 inhibited ccRCC proliferation in vivo and in vitro. Fer-1 treatment decreased the anti-tumor effects of CX3CL1, demonstrating the critical role played by the ferroptosis regulation activity of CX3CL1 in its anti-tumor effect.